坏死性小肠结肠炎
炎症
小肠结肠炎
免疫学
免疫系统
分泌物
医学
癌症研究
平衡
细胞因子
生物
肠道菌群
细胞分化
促炎细胞因子
肠粘膜
细胞
下调和上调
肿瘤坏死因子α
程序性细胞死亡
代谢物
干细胞
肺
免疫
胚胎干细胞
细胞生物学
坏死性下垂
作者
Qin Zhu,Yuyin Wang,Yifan Zhou,Xin Wu,Hongyan Zai,Yu Hu
标识
DOI:10.1038/s42003-025-09438-1
摘要
Necrotizing enterocolitis (NEC) severely affects preterm infants with limited treatments. Although intestinal homeostasis dysfunction is considered a trigger for NEC, the key targets and mechanisms remain unclear. Using lipopolysaccharide-stimulated colonic epithelial cells and hypothermic hypoxia-induced NEC mice (both sexes), we demonstrate that the gut metabolite L-cystine alleviates intestinal inflammation by balancing Th17/Treg responses and inhibiting ferroptosis. Mechanistically, L-cystine directly targets KIF11 to suppress RC3H1 expression, blocking IL-6 transcripts through transcriptional modifications, thereby inhibiting IL-6 secretion and ferroptosis. Conditioned medium from L-cystine-treated cells inactivates IL-6/STAT3 signaling, reducing pro-inflammatory cytokine release and restoring Th17/Treg balance. Notably, microbiota colonization from NEC preterm infants exacerbates intestinal damage, an effect mitigated by L-cystine and IL-6/STAT3 inhibition. Thus, L-cystine attenuates NEC by suppressing ferroptosis in epithelial cells, restoring immune homeostasis, and preserving intestinal barrier integrity. Targeting intestinal metabolites represents a promising prophylactic and therapeutic strategy for NEC, addressing unmet clinical needs in neonatal intestinal injury management.
科研通智能强力驱动
Strongly Powered by AbleSci AI